2,288 followers
RT @BrielmaierL: Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical dru…
RT @BrielmaierL: Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical dru…
RT @BrielmaierL: Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical dru…
Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial https://t.co/KI8nGgiOQj As more longitudinal data are gathered, the role of OM as a biomarker for ALS disease progression may